发布求助
文献互助 智能选刊 最新文献

Oncology Times UK最新文献

筛选
英文 中文
Muscle Quality Could Predict Certain Cancer Outcomes 肌肉质量可以预测某些癌症的结果
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753352.22936.F1
Sarah DiGiulio
{"title":"Muscle Quality Could Predict Certain Cancer Outcomes","authors":"Sarah DiGiulio","doi":"10.1097/01.COT.0000753352.22936.F1","DOIUrl":"https://doi.org/10.1097/01.COT.0000753352.22936.F1","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"32 1","pages":"30-30"},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78871361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idecabtagene Vicleucel (Abecma®)
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753336.18581.7D
A. Robinson
{"title":"Idecabtagene Vicleucel (Abecma®)","authors":"A. Robinson","doi":"10.1097/01.COT.0000753336.18581.7D","DOIUrl":"https://doi.org/10.1097/01.COT.0000753336.18581.7D","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"23 1","pages":"21-21"},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76456290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Vaccine Shows Promise Against Multiple Tumor Types 疫苗有望对抗多种肿瘤
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753376.77500.CB
K. Samson
{"title":"Vaccine Shows Promise Against Multiple Tumor Types","authors":"K. Samson","doi":"10.1097/01.COT.0000753376.77500.CB","DOIUrl":"https://doi.org/10.1097/01.COT.0000753376.77500.CB","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"41 1","pages":"37-37"},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83712423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Broadening Eligibility Criteria in Cancer Clinical Trials 拓宽癌症临床试验的资格标准
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753344.32517.FE
P. Eastman
{"title":"Broadening Eligibility Criteria in Cancer Clinical Trials","authors":"P. Eastman","doi":"10.1097/01.COT.0000753344.32517.FE","DOIUrl":"https://doi.org/10.1097/01.COT.0000753344.32517.FE","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"47 1","pages":"28-28"},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75085611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising Role of Whole Genome Sequencing in Blood Cancers 全基因组测序在血癌研究中的重要作用
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753392.19592.D6
D. Das
{"title":"Promising Role of Whole Genome Sequencing in Blood Cancers","authors":"D. Das","doi":"10.1097/01.COT.0000753392.19592.D6","DOIUrl":"https://doi.org/10.1097/01.COT.0000753392.19592.D6","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"430 2-3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77868186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive Results for Bispecific DART Flotetuzumab in Patients With AML 双特异性DART Flotetuzumab在AML患者中的阳性结果
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753424.47304.EE
R. Simoneaux
{"title":"Positive Results for Bispecific DART Flotetuzumab in Patients With AML","authors":"R. Simoneaux","doi":"10.1097/01.COT.0000753424.47304.EE","DOIUrl":"https://doi.org/10.1097/01.COT.0000753424.47304.EE","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"61 1","pages":"15-15"},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90059051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
What to Expect From the Virtual 2021 ASCO Annual Meeting 从2021年ASCO年会中可以期待什么
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753324.40313.9A
Catlin Nalley
{"title":"What to Expect From the Virtual 2021 ASCO Annual Meeting","authors":"Catlin Nalley","doi":"10.1097/01.COT.0000753324.40313.9A","DOIUrl":"https://doi.org/10.1097/01.COT.0000753324.40313.9A","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"8 1","pages":"6-6"},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89691795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing HER2-Positive Breast Cancer Amid COVID-19 在COVID-19期间管理her2阳性乳腺癌
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753308.75899.F7
R. Usman, E. Miller, G. Vidal
{"title":"Managing HER2-Positive Breast Cancer Amid COVID-19","authors":"R. Usman, E. Miller, G. Vidal","doi":"10.1097/01.COT.0000753308.75899.F7","DOIUrl":"https://doi.org/10.1097/01.COT.0000753308.75899.F7","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84801250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pevonedistat-Azacitidine for Myeloid-Based Malignancies 培地司他-阿扎胞苷治疗髓系恶性肿瘤
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753396.44941.09
R. Simoneaux
{"title":"Pevonedistat-Azacitidine for Myeloid-Based Malignancies","authors":"R. Simoneaux","doi":"10.1097/01.COT.0000753396.44941.09","DOIUrl":"https://doi.org/10.1097/01.COT.0000753396.44941.09","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79981006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Link Between Prostate Cancer Risk & a Healthy Lifestyle 前列腺癌风险与健康生活方式之间的联系
Oncology Times UK Pub Date : 2021-05-20 DOI: 10.1097/01.COT.0000753364.25264.F5
Warren Froelich
{"title":"The Link Between Prostate Cancer Risk & a Healthy Lifestyle","authors":"Warren Froelich","doi":"10.1097/01.COT.0000753364.25264.F5","DOIUrl":"https://doi.org/10.1097/01.COT.0000753364.25264.F5","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"84 1","pages":"34-34"},"PeriodicalIF":0.0,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76446052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信